Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems (NYSE:INSP) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership.

Does the media refer more to INSP or SNN?

In the previous week, Smith & Nephew had 2 more articles in the media than Inspire Medical Systems. MarketBeat recorded 7 mentions for Smith & Nephew and 5 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.47 beat Smith & Nephew's score of 0.90 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of INSP or SNN?

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 25.6% of Smith & Nephew shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by company insiders. Comparatively, 1.0% of Smith & Nephew shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is INSP or SNN more profitable?

Inspire Medical Systems has a net margin of 6.67% compared to Smith & Nephew's net margin of 0.00%. Inspire Medical Systems' return on equity of 8.19% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	6.67%	8.19%	7.09%
Smith & Nephew	N/A	N/A	N/A

Do analysts recommend INSP or SNN?

Inspire Medical Systems currently has a consensus target price of $211.91, indicating a potential upside of 60.02%. Smith & Nephew has a consensus target price of $28.00, indicating a potential downside of 7.08%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, research analysts clearly believe Inspire Medical Systems is more favorable than Smith & Nephew.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Smith & Nephew	0 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more volatility & risk, INSP or SNN?

Inspire Medical Systems has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500.

Does the MarketBeat Community favor INSP or SNN?

Smith & Nephew received 251 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. However, 61.88% of users gave Inspire Medical Systems an outperform vote while only 54.10% of users gave Smith & Nephew an outperform vote.

Company	Underperform	Outperform
Inspire Medical Systems	Outperform Votes 198 61.88%	Underperform Votes 122 38.13%
Smith & Nephew	Outperform Votes 449 54.10%	Underperform Votes 381 45.90%

Which has higher earnings and valuation, INSP or SNN?

Smith & Nephew has higher revenue and earnings than Inspire Medical Systems. Smith & Nephew is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$840.11M	4.65	$53.51M	$2.17	61.03
Smith & Nephew	$5.81B	2.27	$263M	$2.16	13.95

Summary

Inspire Medical Systems beats Smith & Nephew on 14 of the 18 factors compared between the two stocks.